Kocitaf combines three antiretroviral medicines from complementary drug classes. Dolutegravir inhibits HIV integrase, while emtricitabine and tenofovir alafenamide inhibit HIV reverse transcriptase.
Together, they reduce HIV replication and help maintain viral suppression when taken consistently as part of an appropriate HIV treatment regimen. more info
Uses
- Treatment of HIV-1 infection as part of an appropriate antiretroviral regimen
Active Ingredients
- Dolutegravir 50mg
- Emtricitabine 200mg
- Tenofovir Alafenamide 25mg
How to Take
- Take exactly as prescribed by an HIV-treatment specialist.
- Take consistently at approximately the same time each day.
Precautions
- Prescription-only antiretroviral medicine.
- Do not stop treatment without medical advice.
- Check for interactions with antacids, mineral supplements and other medicines.
- Kidney and liver function may require monitoring
